Clinical trial
Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent…
NCT00283413 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00283413 |
|---|---|
| Title | Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts |
| Official title | Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Symptomatic Ischemic Saphenous Vein Graft Disease |
| Intervention type | Device |
| Interventions | Covered Stent System, Bare metal stent |
| Enrollment | 514 |
| Start date | Mar 1, 2002 |
| Primary completion | May 1, 2004 |
| Completion | Mar 1, 2009 |
| First posted | Jan 30, 2006 |
| Last update posted | Nov 2, 2009 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: